Avita Medical
Encyclopedia
Avita Medical develops spray-on skin
processes to treat skin trauma
, including burn
s. They market their artificial skin
products under the names CellSpray and ReCell. According to Avita, ReCell has been approved for marketing and sale in Europe, Canada and Australia.
Originally named "Clinical Cell Culture" , the company restructured under the name "Avita Medical" in June 2008 with a new CEO
, William Dolphin.
.
Spray-on skin
Spray-on skin is a patented skin culturing treatment for burns victims, developed by scientist Marie Stoner and plastic surgeon Dr Fiona Wood of Perth, Western Australia....
processes to treat skin trauma
Skin trauma
Skin trauma is when the skin or multiple layers of epithelial tissues experience serious and altering physical injury. This can be in the form of cuts, burns, sickness or other injury....
, including burn
Burn
A burn is an injury to flesh caused by heat, electricity, chemicals, light, radiation, or friction.Burn may also refer to:*Combustion*Burn , type of watercourses so named in Scotland and north-eastern England...
s. They market their artificial skin
Artificial skin
Artificial skin can refer to skin grown in a laboratory that can be used as skin replacement for people who have suffered skin trauma such as severe burns or skin diseases.Alternatively, it can also refer to skin synthetically produced for other purposes....
products under the names CellSpray and ReCell. According to Avita, ReCell has been approved for marketing and sale in Europe, Canada and Australia.
Originally named "Clinical Cell Culture" , the company restructured under the name "Avita Medical" in June 2008 with a new CEO
Chief executive officer
A chief executive officer , managing director , Executive Director for non-profit organizations, or chief executive is the highest-ranking corporate officer or administrator in charge of total management of an organization...
, William Dolphin.
US Government grant
In 2009 the United States Armed Forces Institute of Regenerative Medicine provided Avita with a US$1.45 million grant to hasten the approval of the ReCell kit with the U.S. Food and Drug AdministrationFood and Drug Administration
The Food and Drug Administration is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments...
.